Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting

BACKGROUND: Liraglutide is an analog of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor agonist. Liraglutide is presently used in the treatment of selected patients with type 2 diabetes mellitus (T2DM). OBJECTIVE: To assess efficacy and safety of liraglutide in, overweight and obe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesavadev, Jothydev, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333831/
https://www.ncbi.nlm.nih.gov/pubmed/22536087
http://dx.doi.org/10.2147/IJGM.S27886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333831/
https://www.ncbi.nlm.nih.gov/pubmed/22536087
http://dx.doi.org/10.2147/IJGM.S27886

Ejemplares similares